Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-05-05 @ 12:00 AM
Study NCT ID:
NCT05400902
Status:
UNKNOWN
Last Update Posted:
2023-04-13
First Post:
2022-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Binkui Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B2022-233-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None